2023
Entrant
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant
SFC Group
Category
Website - Associations
Country / Region
United States
Entrant
Get Well
Category
Provider & Services - Patient Engagement
Country / Region
United States
Entrant
Alma Audiovisual
Category
Video, Commercial & Film - Budget > $3000
Country / Region
Spain
Entrant
Courageous Studios
Category
Video, Commercial & Film - Medical
Country / Region
United States